SCHEMBL7610709

SCHEMBL7610709

CCCCCCCC/C=C\CCCCCCCC(=O)OC(C)(C)S(=O)(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 5/20 0.50
▸ TERT O14746 3/20 0.50
▸ PTPN1 P18031 3/20 0.50
▸ PPARG P37231 3/20 0.50
▸ PPARD Q03181 3/20 0.50
▸ PPARA Q07869 3/20 0.50
▸ CYP1A2 P05177 2/20 0.50
▸ MAPT P10636 2/20 0.50
▸ CYP2C19 P33261 2/20 0.50
▸ BLM P54132 2/20 0.50
▸ HSD17B10 Q99714 2/20 0.50
▸ FABP4 P15090 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ GMNN O75496 1/20 0.50
▸ USP2 O75604 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ POLB P06746 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ ALOX15 P16050 1/20 0.50
▸ APEX1 P27695 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7610717 1.00 FAAH (0.50) FAAHTERTPTPN1PPARGPPARD
SCHEMBL3660737 0.83 FAAH (0.58) FAAHTERTPTPN1PPARGPPARD
SCHEMBL4263808 0.83 FAAH (0.58) FAAHTERTPTPN1PPARGPPARD
SCHEMBL3660734 0.83 FAAH (0.58) FAAHTERTPTPN1PPARGPPARD
Ammonia Solution, Strong SCHEMBL8661313 0.81 FAAH (0.56) FAAHTERTPTPN1PPARGPPARD
SCHEMBL7118074 0.81 EPHX2 (0.46) FAAHTERTPTPN1PPARGPPARD
SCHEMBL28508425 0.81 FAAH (0.49) FAAHTERTPTPN1PPARGPPARD
SCHEMBL8678813 0.80 FAAH (0.54) FAAHTERTPTPN1PPARGPPARD
SCHEMBL8678818 0.80 FAAH (0.54) FAAHTERTPTPN1PPARGPPARD
SCHEMBL28005812 0.80 FAAH (0.59) FAAHTERTPTPN1PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020164368-A1 Male contraceptive method and composition ZIMMERMAN RONALD (US) 2002-11-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020164368-A1 Male contraceptive method and composition PGRMC2, PGRMC1, CYP19A1 FAAH 1350/4885TERT 4308/4885PTPN1 763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback